Trial Details

Recruiting
Basic Information
Clinical ID c2131
Identifier DRKS00033067
Trial Title Epigenetic Profiling in Inflammatory Bowel Disease Patients
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Crohn's Disease and Ulcerative Colitis
Interventions Group 1: 25 participants with preliminary diagnosis of active Crohn's Disease will provide data via a single study-specific questionnaire within 4 weeks of a (ileo)colonoscopy. Blood, buccal, saliva and optional stool samples will be collected within 2 weeks of the (ileo)colonoscopy. Group 2: 25 participants with preliminary diagnosis of active Ulcerative Colitis will provide data via a single study-specific questionnaire within 4 weeks of a (ileo)colonoscopy. Blood, buccal, saliva and optional stool samples will be collected within 2 weeks of the (ileo)colonoscopy. Group 3: 25 healthy control participants will provide data via a single study-specific questionnaire within 4 weeks of a (ileo)colonoscopy. Blood, buccal, saliva and optional stool samples will be collected within 2 weeks of the (ileo)colonoscopy. Group 4: 10-25 participants with other selected inflammatory diseases (diverticulitis, microscopic colitis, diverticular colitis, rheumatoid arthritis, other) will provide data via a single study-specific questionnaire within 4 weeks of a (ileo)colonoscopy. Blood, buccal, saliva and optional stool samples will be collected within 2 weeks of the (ileo)colonoscopy.
Participant Information
Sponsor Evonik Operations GmbH
City -
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type observational
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -